Clinical Trial Update: Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

View source ↗

Summary

Prospective non-interventional trial evaluating outcomes for EGFR-mutated non-small cell lung cancer patients treated with osimertinib with or without chemother…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Osimertinib (osimertinib)

Snippet

Sponsor: PrECOG, LLC. | Conditions: Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation | Status: RECRUITING